Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosis
Open Access
- 4 March 2022
- journal article
- research article
- Published by Elsevier in Clinics in Dermatology
- Vol. 40 (4) , 397-401
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Widespread cutaneous small vessel vasculitis secondary to COVID‐19 infectionInternational Journal of Dermatology, 2020
- COVID-19-associated vasculitis and vasculopathyJournal of Thrombosis and Thrombolysis, 2020
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19Journal of Allergy and Clinical Immunology, 2020
- A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID‐19Journal of the European Academy of Dermatology and Venereology, 2020
- Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 casesBritish Journal of Dermatology, 2020
- Elevated interleukin‐6 and severe COVID‐19: A meta‐analysisJournal of Medical Virology, 2020
- Cutaneous small‐vessel vasculitis associated with novel 2019 coronavirus SARS‐CoV‐2 infection (COVID‐19)Journal of the European Academy of Dermatology and Venereology, 2020
- Cutaneous small vessel vasculitis secondary to COVID‐19 infection: a case reportJournal of the European Academy of Dermatology and Venereology, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004